Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020
Research

Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012

Lauren C. RamsayComments to Author , Emily Shing, John Wang, Theodore K. Marras, Jeffrey C. Kwong, Sarah K. Brode, Frances B. Jamieson, and Beate Sander
Author affiliations: University Health Network, Toronto, Ontario, Canada (L.C. Ramsay, T.K. Marras, J.C. Kwong, S.K. Brode, B. Sander); University of Toronto, Toronto (L.C. Ramsay, T.K. Marras, J.C. Kwong, S.K. Brode, F.B. Jamieson, B. Sander); Public Health Ontario, Toronto (E. Shing, J. Wang, J.C. Kwong, F.B. Jamieson, B. Sander); ICES, Toronto (J. Wang, J.C. Kwong, S.K. Brode, B. Sander); West Park Healthcare Centre, Toronto (S.K. Brode)

Main Article

Table 4

Ten-day mean attributable costs by phase for nontuberculous mycobacterial pulmonary disease and nontuberculous mycobacterial pulmonary isolation, Ontario, 2001–2012*

Spending category (no. patients) Cost, CAD
Exposed persons Unexposed persons Attributable (95% CI)
Nontuberculous mycobacterial pulmonary disease
Initial infection (6,906)
Total 1,209 232 977 (905–1,048)
Hospitalization 724 61 663 (603–723)
Emergency department 35 6 29 (27–31)
Drugs 60 37 23 (19–26)
Physicians 232 45 187 (177–196)
Other 158 83 75 (62–88)
Subsequent care (6,906)
Total 713 218 494 (438–549)
Hospitalization 360 55 305 (258–352)
Emergency department 12 6 6 (5–7)
Drugs 67 37 30 (26–34)
Physicians 114 41 73 (68–79)
Other 160 80 80 (65–95)
Continuous care (6,489)
Total 530 294 236 (199–272)
Hospitalization 196 75 120 (92–149)
Emergency department 13 8 5 (4–6)
Drugs 73 43 29 (26–33)
Physicians 77 45 33 (30–36)
Other 171 123 48 (34–61)
Before-death (2,835)
Total 5,300 3,947 1,352 (1,104–1,601)
Hospitalization 3,757 2,492 1,265 (1,032–1,497)
Emergency department 111 108 2 (−2 to 6)
Drugs 110 105 5 (−3 to 14)
Physicians 573 417 156 (130–182)
Other
749
 825
 −76 (−128 to −24)
Nontuberculous mycobacterial pulmonary isolation
Initial infection (8,171)
Total 822 189 633 (591–676)
Hospitalization 464 49 415 (381–449)
Emergency department 32 5 27 (25–29)
Drugs 48 30 18 (15–20)
Physicians 158 38 120 (114–125)
Other 121 67 54 (42–67)
Subsequent care (8,171)
Total 436 183 253 (222–284)
Hospitalization 178 45 133 (109–156)
Emergency department 11 5 6 (5–7)
Drugs 51 30 21 (17–24)
Physicians 80 37 43 (40–47)
Other 117 67 50 (39–62)
Continuous care (7,860)
Total 387 253 133 (111–154)
Hospitalization 122 64 57 (42–72)
Emergency department 11 7 4 (3–5)
Drugs 57 36 22 (19–25)
Physicians 60 40 20 (18–22)
Other 136 106 29 (19–40)
Before death (2,374)
Total 4,532 3,800 731 (506–958)
Hospitalization 3,088 2,351 736 (524–949)
Emergency department 124 108 17 (12–22)
Drugs 108 101 7 (−1 to 15)
Physicians 474 412 62 (40–83)
Other 738 827 −90 (−146 to −34)

*Costs presented in 2018 Canadian dollars (CAD). In 2018, $1 CAD = $0.77 US dollars.

Main Article

Page created: July 10, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external